Steven H. Pickett

We don’t have enough information about this author to calculate their statistics. If you think this is an error let us know.
Learn More
Non-specific immunotherapy of superficial bladder cancer using Bacillus Calmette-Guérin (BCG) represents a successful application of immunotherapy against a human cancer. Clinical studies in the late 1970's first demonstrated the efficacy of this form of therapy against papillary forms of transitional cell carcinoma. Subsequent studies confirmed the value(More)
Successful treatment of superficial bladder cancer using nonspecific immunotherapy with Bacillus Calmette-Guerin (BCG) has been well documented. Investigation of two potential tumor-specific immunotherapeutic agents using a murine transitional-cell carcinoma model (MBT-2) is reported. The survival of mice immunized with tumor proteins obtained by treating(More)
  • 1